 Celldex Therapeutics is a biopharmaceutical company focused on developing monoclonal and bispecific antibody-based therapeutics. Celldexs new pipeline is now made up of 3 Phase 1 immunotherapiestargeted biologics aiming to primarily treat various cancers and autoimmune diseases. 